Myotonia Congenita and Myotonic Dystrophy: Surveillance and Management

被引：0
|
作者：
Allison Conravey
Lenay Santana-Gould
机构：
[1] Tulane University,Department of Pediatrics
来源：
Current Treatment Options in Neurology | 2010年 / 12卷
关键词：
Modafinil; Myotonic Dystrophy; Malignant Hyperthermia; Fenoterol; Creatine Monohydrate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Myotonia can be treated both pharmacologically and by lifestyle modifications. Cell membrane stabilizers are the medications most commonly used for symptomatic treatment of myotonia. Most patients do not require treatment for the myotonia itself, unless it is severe, but physicians must be aware of anesthesia risks in both myotonia congenita and myotonic dystrophy. A mainstay of management of myotonic dystrophy is the surveillance and treatment of its various systemic complications.
引用
收藏
页码：16 / 28
页数：12
相关论文
共 50 条
12345